What are the limitations of the lung rads v2022?

While the lung rads v2022 is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the lung rads v2022 to ensure safe bedside use and optimal diagnostic accuracy.

How does the lung rads v2022 compare to other Oncology scores?

The lung rads v2022 is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the lung rads v2022 free to use?

Yes. OpiCalc provides the lung rads v2022 completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

Lung-RADS v2022

Lung Cancer

Screening CT nodule management categorization.

Nodule type

Largest size

Spiculation or other highly suspicious feature

Waiting For Required Inputs

Complete the required fields to generate the oncology interpretation.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Screening CT nodule management categorization.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Nodule type

Largest size

Spiculation or other highly suspicious feature

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Screening CT nodule management categorization.

OpiCalc Medical Oncology ModuleLung Cancer2026

CLINICAL INSIGHT

Background

Context

Lung-RADS v2022 is included in the oncology module as a structured decision-support tool for lung cancer workflows.

No clinical reference data available.

Lung-RADS v2022

Lung Cancer

Screening CT nodule management categorization.

Nodule type

Largest size

Spiculation or other highly suspicious feature

Waiting For Required Inputs

Complete the required fields to generate the oncology interpretation.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Screening CT nodule management categorization.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Nodule type

Largest size

Spiculation or other highly suspicious feature

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Screening CT nodule management categorization.

OpiCalc Medical Oncology ModuleLung Cancer2026

CLINICAL INSIGHT

Background

Context

Lung-RADS v2022 is included in the oncology module as a structured decision-support tool for lung cancer workflows.

No clinical reference data available.